Ubs Asset Management Americas Inc Maravai Lifesciences Holdings, Inc. Transaction History

Ubs Asset Management Americas Inc

$417 Billion
Q4 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 251,214 shares of MRVI stock, worth $713,447. This represents 0.0% of its overall portfolio holdings.

Number of Shares

251,214

Previous 205,760 22.09%

Holding current value

$713,447

Previous $1.71 Million 19.89%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$4.42 - $8.5 $200,906 - $386,359	45,454 Added 22.09%	251,214 $1.37 Million
Q3 2024 Nov 14, 2024	SELL	$6.84 - $9.73 $195,535 - $278,151	-28,587 Reduced 12.2%	205,760 $1.71 Million
Q2 2024 Aug 13, 2024	BUY	$6.87 - $11.34 $256,141 - $422,800	37,284 Added 18.92%	234,347 $1.68 Million
Q4 2023 Feb 14, 2024	SELL	$4.7 - $9.87 $2.04 Million - $4.28 Million	-433,332 Reduced 68.74%	197,063 $1.29 Million
Q3 2023 Nov 13, 2023	SELL	$9.14 - $12.85 $6.88 Million - $9.67 Million	-752,375 Reduced 54.41%	630,395 $6.3 Million
Q1 2023 May 15, 2023	BUY	$12.99 - $16.48 $18 Million - $22.8 Million	1,382,770 New	1,382,770 $19.4 Million
Q3 2022 Nov 14, 2022	SELL	$20.6 - $30.37 $6.45 Million - $9.51 Million	-312,997 Reduced 12.69%	2,152,901 $55 Million
Q2 2022 Aug 12, 2022	SELL	$26.05 - $37.48 $7.02 Million - $10.1 Million	-269,506 Reduced 9.85%	2,465,898 $70.1 Million
Q1 2022 May 16, 2022	SELL	$24.46 - $40.92 $43.6 Million - $72.9 Million	-1,780,696 Reduced 39.43%	2,735,404 $96.5 Million
Q4 2021 Feb 14, 2022	BUY	$35.0 - $45.94 $13.4 Million - $17.6 Million	382,914 Added 9.26%	4,516,100 $189 Million
Q3 2021 Nov 15, 2021	BUY	$36.8 - $60.62 $21.9 Million - $36 Million	594,447 Added 16.8%	4,133,186 $203 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $45.0 $8.08 Million - $11.2 Million	248,796 Added 7.56%	3,538,739 $148 Million
Q1 2021 May 14, 2021	SELL	$25.8 - $38.49 $12.2 Million - $18.2 Million	-473,069 Reduced 12.57%	3,289,943 $117 Million
Q4 2020 Mar 01, 2021	BUY	$24.5 - $30.86 $92.2 Million - $116 Million	3,763,012 New	3,763,012 $106 Million

Others Institutions Holding MRVI

# of Institutions

203

Shares Held

138M

Call Options Held

271K

Put Options Held

37.6K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $374M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Maravai Lifesciences Holdings, Inc. Transaction History